Brazil Continuous Glucose Monitoring Market - Strategic Insights and Forecasts (2026-2031)

The Brazil Continuous Glucose Monitoring (CGM) market is forecast to grow at a CAGR of 21.6% during the projection period. It is expected to reach USD 0.16 billion in 2031, significantly expanding from USD 0.06 billion in 2026.

In Brazil, the continuous glucose monitoring market is segmented by application and end-user. This segmentation allows for a detailed analysis of the different areas where CGM devices are utilized and the types of consumers driving demand within the country.

The market's growth is primarily driven by the high prevalence of type 1 and type 2 diabetes, affecting over 15.7 million Brazilian adults in 2021. Additionally, rising government initiatives and educational programs on diabetic health and care, coupled with the decreasing cost of CGM devices, are positively impacting demand.

The growth of the Brazilian CGM market is being obstructed by the high price of CGM devices, which can limit accessibility for many patients. Furthermore, the lack of comprehensive reimbursement policies from medical insurance providers in the country poses a significant challenge during the analysis period.

The prevalence of diabetes is a critical factor; 1 in 10 Brazilian adults, or over 15.7 million people, had diabetes in 2021, with 18.9% having impaired glucose tolerance. This alarming increase due to lifestyle changes necessitates CGM devices for managing blood glucose levels to prevent severe consequences, thereby directly fueling market demand.

A key trend is the increasing recognition of CGM as a widely used and advantageous technology for diabetics, ensuring continuous blood sugar tracking. Studies highlight benefits such as a shorter duration of hypoglycemia and lower levels of glycated haemoglobin, which are crucial for managing diabetes and improving patient outcomes in Brazil.